Immunohistochemical detection of XIAP in melanoma

Journal of Cutaneous Pathology

Volumn 35, Issue 3, 2008, Pages 292-297

  Emanuel, Patrick O M ^a   Phelps, Robert G ^a   Mudgil, Adarsh ^a   Shafir, Michail ^a   Burstein, David E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CONTROLLED STUDY; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; NEVUS; PROTEIN BINDING; PROTEIN EXPRESSION;

CELL COUNT; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 38649083722     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00798.x     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006 56 : 106.
2. Gonzalez Cao M, Malvehy J, Marti R, et al. Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-a in patients with metastatic melanoma. Melanoma Res 2006 16 : 59.
3. ®640. Ann N Y Acad Sci 2005 1058 : 215.
4. Ng KC, Campos EI, Martinka M, et al. XAF1 expression is significantly reduced in human melanoma. J Invest Dermatol 2004 123 : 1127.
5. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev 1999 13 : 239.
6. Byun DS, Cho K, Ryu BK, et al. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 2003 63 : 7068.
7. Wu TY, Wagner KW, Bursulaya B, et al. Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/Caspase-3 interaction. Chem Biol 2003 10 : 759.
8. Posther KE, Selim MA, Mosca PJ, et al. Histopathologic characteristics, recurrence patterns, and survival of 129 Patients with desmoplastic melanoma. Ann Surg Oncol 2006 13 : 728.
9. Ding Y, Prieto VG, Zhang PS, et al. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma. Cancer 2006 106 : 1123.
10. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003 63 : 6815.
11. Li J, Feng Q, Kim JM, et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 2001 142 : 370.
12. Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med 2006 355 : 51.
13. Reintgen D, Balch CM, Kirkwood J, Ross M. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997 225 : 1.
14. Balch CM. Cutaneous melanoma. In Greene FL, Page DL, Fleming ID, Fritz A, eds. AJCC cancer staging manual, 6th ed. New York, NY : Springer Verlag, 2002 209.
15. Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: a case - control study of 43 cases. Arch Dermatol 2002 138 : 603.
16. Cook MG, Spatz A, Brocker EB, Ruiter DJ. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol 2002 197 : 188.
17. Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg 2003 238 : 528.
18. Schimmer AD, Welsh K, Pinilla C, et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 2004 5 : 25.
19. Bilim V, Kasahara T, Hara N, et al. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 2003 103 : 29.
20. Cummings J, Ward TH, LaCasse E, et al. Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer 2005 92 : 532.
21. Rutherford TD, Makkenchery A, Mor G. Phenoxodiol phase Ib/II study in patients with recurrent ovarian cancer that are resistant to second line chemotherapy. J Soc Gynecol Invest 2004 11 : 254.